Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanoma
Human Pathology Feb 25, 2018
Xu T, et al. - This study was conducted in order to comparatively explore the gene expression profiles of primary and lymph node metastatic acral melanoma (AM) tissues. In contrast with the primary tumors, the expression levels of 396 genes were increased, and that of 766 genes were decreased in the metastatic tissues. Based on the yielded data, experts defined the gene expression signature of AM metastasis and illustrated that cell division cycle-associated 5 (CDCA5) served as a potential therapeutic target in AM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries